DevonLivingston-RosanoffMDPhd

General Surgery Resident

Dr. Livingston-Rosanoff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
University of Wisconsin Department of Surgery Administration MC: 7375
600 Highland Avenue
Madison, WI 53792

PubMed

3 citations
Breast Cancer Outcomes of Neoadjuvant Versus Adjuvant Chemotherapy by Receptor Subtype: A Scoping Review
Trista J. Stankowski-Drengler, Devon Livingston-Rosanoff, Jessica R. Schumacher, Bret Hanlon, Mary E Hitchcock
The Journal of Surgical Research. 2020-05-15
820 citations
RIP3 mediates the embryonic lethality of caspase-8-deficient mice
William J. Kaiser, Jason W. Upton, Alyssa B. Long, Devon Livingston-Rosanoff, Lisa P. Daley-Bauer
Nature. 2011-03-17
2 citations
Outcomes for Patients with Residual Stage II/III Breast Cancer Following Neoadjuvant Chemotherapy (AFT-01)
Trista J. Stankowski-Drengler, Jessica R. Schumacher, Bret Hanlon, Devon Livingston-Rosanoff, K. Van de Walle
Annals of Surgical Oncology. 2020-01-03

Graduate StudentStudied the contribution of T cells in the pathophysiology of CMV infections. Also evaluated the role of cell death pathways in the antiviral T cell response. This work culminated in my PhD.2008 - 2013
Research TechnicianStudied a cohort of people repeatedly exposed to HIV but who remained seronegative (exposed seronegatives) and evaluated differences in their CD4 and CD8 T cell response to HIV infection.2003 - 2006